By Maggie Fick, Patrick Wingrove and Elissa Welle LONDON/NEW YORK (Reuters) - Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy...
Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine. Wegovy is a weekly injection that can help patients shed 15% of their weight alongside diet and exercise changes. Walgreens, one of the biggest U.S. pharmacies, is experiencing supply shortages for the higher strengths, spokesperson Erin Love
DIABESITY DIALOGUES | Patient Perspectives for PCPs: Tackling the Treatment Paradigms of Obesity, T2D, and Other Metabolic Disorders healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.